Venous Thromboembolism Clinical Trial
Official title:
Educating Nurses About Venous Thromboembolism Prevention
As part of mandatory on-going nursing education, the investigators have incorporated
identical information into two distinct web-based learning formats - the traditional linear
PowerPoint format (with voice-over) and a new interactive format developed with central
nursing education.
The investigators will cluster randomize nurses by floor to receive either the traditional
education or the new interactive education, and evaluate the impact on administration of VTE
prophylaxis doses administered by nurses before and after education. All nurses on a floor
will receive the same educational format. If one method of education results in statistically
significant improvement in VTE prophylaxis administration, the investigators will cross over
to deliver the superior education format to all nurses who originally were given the less
effective method.
BACKGROUND
- In an attempt to improve venous thromboembolism (VTE) prophylaxis adherence the
investigators carried out qualitative studies to obtain patients' viewpoints on how
nurses should be educated about VTE prevention and to assess nurses' beliefs and
perceptions about pharmacologic VTE prophylaxis
- The investigators observed deficiencies in nurses' knowledge and misconceptions about
VTE prophylaxis that likely lowers adherence to administration of prescribed VTE
prophylaxis doses
- As a part of our original Patient-Centered Outcomes Research Institute (PCORI) proposal,
the investigators planned to educate nurses to address the observed deficiencies and
misconceptions and improve their ability to communicate effectively with patients
- Historically, nurse education has been done via a linear, PowerPoint-based platform
with voice-over but with no interactive component (TRADITIONAL)
- A newer platform for nurse education became available for use and includes
scenario-based teaching, ongoing assessment, and immediate remediation. Most
importantly, it is a highly interactive product (CONTEMPORARY)
STUDY DESIGN AND ANALYTIC PLAN
- Research hypotheses
- Primary: Nurse participants who receive either of these interventions will improve
administration of prescribed VTE prophylaxis evidenced by a decrease in frequency
of non-administered doses of VTE prophylaxis, compared with their frequency at
baseline.
- Secondary: Nurse participants who receive the contemporary education format will
have a larger decrease in frequency of missed doses of VTE prophylaxis compared
with those who participate in the traditional education format.
- Study Design
- Cluster Randomized Trial 21 floors, block randomized by floor type (medicine [n=11]
vs. surgery [n=10]) and (ICU [n=5] vs. non-ICU [n=16]) All nurses on each floor are
assigned the same education type to mitigate issues related to contamination if
nurses discuss the education with their colleagues
- Primary Outcome measure: Proportion of non-administered doses of pharmacological VTE
prophylaxis (dose level)
- Secondary Outcome Measures:
- Proportion of doses documented as missed due to patient refusal (dose level)
- Proportion of patients with any VTE (patient level)
- Proportion of patients with Deep Vein Thrombosis (DVT) (patient level)
- Proportion of patients with Pulmonary Embolism (PE) (patient level)
- Analytic methods
- Primary analyses - Intention-to-treat (includes all nurses assigned, whether or not
they completed the education) Is there a difference between units allocated to
either of the interventions comparing their outcome measure to their baseline
measure? Is there a difference comparing those who received the contemporary
education format vs. the traditional education format?
- Secondary analysis - Per protocol (includes only nurses who completed the
education) Do nurses who receive education perform better (improved administration
of prescribed VTE prophylaxis) than those who did not? Do nurses who received the
education in the contemporary format perform better than those who received it in
the traditional format
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05347550 -
Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
|
N/A | |
Enrolling by invitation |
NCT05794165 -
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
|
Phase 2 | |
Completed |
NCT02379806 -
The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study
|
Phase 3 | |
Recruiting |
NCT03691753 -
Safety and Efficacy Study of Fitaya Vena Cava Filter
|
N/A | |
Completed |
NCT02197416 -
Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
|
Phase 3 | |
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Recruiting |
NCT05171075 -
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
|
Phase 3 | |
Completed |
NCT01895777 -
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
|
Phase 3 | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Completed |
NCT04736719 -
Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
|
||
Completed |
NCT04736420 -
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
|
||
Completed |
NCT04735523 -
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
|
||
Completed |
NCT02829957 -
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding
|
Phase 2/Phase 3 | |
Completed |
NCT02912234 -
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
|
Phase 1 | |
Completed |
NCT02746185 -
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban
|
Phase 3 | |
Completed |
NCT02334007 -
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT02223260 -
Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age
|
Phase 2 | |
Completed |
NCT02661568 -
Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)
|
N/A | |
Completed |
NCT01431456 -
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
|
Phase 3 | |
Completed |
NCT01976988 -
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery
|
Phase 3 |